Accordingly, overexpression of PIK3R1 has been shown to increase the sensitivity of gemcitabine treatment of PCA cells and higher expression of this gene was associated with a decreased in PI3K/AKT signalling pathway activation and increased survival of the patients [84]. This evidence concerns the gene PIK3CG and posterior cortical atrophy.